- Home
- » Tags
- » Nitrosourea
Top View
- DRUG NAME: Lomustine
- Ceenu Product Monograph
- Cross-Resistance to Camptothecin Analogues in a Mitoxantrone-Resistant Human Breast Carcinoma Cell Line Is Not Due to DNA Topoisomerase I Alterations
- Studies on the Chemotherapy of Experimental Brain Tumors: Eval Uation of L,3-Bis(2-Chloroethyl)-L-Nitrosourea, Cyclophosphamide, Mithramycin, and Methotrexate
- Fluorescence-Guided High-Grade Glioma Surgery More Than Four Hours After 5-Aminolevulinic Acid Administration
- From Old Alkylating Agents to New Minor Groove Binders
- TEMODAR® (Temozolomide)
- Carmustine Obvius 100 Mg Powder and Solvent for Concentrate for Solution for Infusion
- Alkylation and Carbamylation Effects of Lomustine and Its Major Metabolites and MGMT Expression in Canine Cells
- A Methionine-Free Diet Associated with Nitrosourea Treatment Down-Regulates Methylguanine-DNA Methyl Transferase Activity in Patients with Metastatic Cancer
- 1-Nitrosourea, a Chemotherapeutic Alkylating Agent (Chloroethylnitrosourea/Retroviral Vector/DNA Repair/06-Methylguanine DNA Methyltransferase) RODNEY MAZE*T, JAMES P
- Photodynamic Therapy for Multi-Resistant Cutaneous
- BICNU (Carmustine) Injection Label
- Temodal, INN- Temozolomide
- 'How Did Lomustine Become Standard of Care In
- Metabolism of Lomustine in Dogs and Comparative
- TEMODAR (Temozolomide) Capsules Observed Closely for the Development of Lymphopenia and PCP
- Cytochrome P450 3A-Mediated Metabolism of the Topoisomerase I Inhibitor 9-Aminocamptothecin: Ιmpact on Cancer Therapy
- Dependence of the Cytotoxicity of DNA-Damaging Agents on the Mismatch Repair Status of Human Cells
- Capacity of Individual Chronic Lymphatic Leukemia Lymphocytes and Leukemic Blast Cells for Repair of O6-Ethylguanine In
- Detection of the P53 Response in Zebrafish Embryos Using
- Highly Penetrative, Drug-Loaded Nanocarriers Improve Treatment of Glioblastoma
- Exploiting Nucleophilic Attack in Chemotherapy Pooja Venkatesh Agnes Scott College
- Preclinical Antitumor Activity of Temozolomide in Mice: Efficacy Against Human Brain Tumor Xenografts and Synergism with 1,3-Bis(2-Chloroethyl)-1-Nitrosourea'
- ( 12 ) United States Patent ( 10 ) Patent No.: US 10,610,125 B2 Dang Et Al
- Nitrosourea Chemotherapeutic Agents
- Ledaga, INN-Chlormethine
- NF-Κb and Therapeutic Approach
- LOMUSTINE - Lomustine Capsule, Gelatin Coated Nextsource Biotechnology, LLC
- Repurposing of Anticancer Drugs for the Treatment of Bacterial Infections Valerie W. C. Soo1£, Brian W. Kwan 1£, Héctor Queza
- DX-8951F), Infused Over 30 Minutes Every Three Weeks1
- Effect of Drug Exposure Duration and Sequencing on Hyperthermic Potentiation of Mitomycin-C and Cisplatin1
- 5-Aminolevulinic Acid-Induced Protoporphyrin IX with Multi-Dose Ionizing Irradiation Enhances Host Antitumor Response and Strong
- Antineoplastic Drugs